Latest filing published 04 Sept 2024 for Calliditas Therapeutics AB, €1.0M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Elmar Schnee: trading record in brief
Elmar Schnee appears in our data through filings on Calliditas Therapeutics AB shares, published by Finansinspektionen. In total, 6 filings cover trades dated from 25 August 2021 to 2 September 2024.
Market trades split into 3 purchases (€281k) and 1 sale (€1.0M). On balance, insiders were net sellers of €761k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants. 2024 to date brings no purchases and 1 sale.
Half of the purchases are above €94k and half below.
Most recently, on 4 September 2024, the filings show an open-market sale worth €1.0M in Calliditas Therapeutics AB. The latest purchase dates back some time: it was published 1,223 days ago, on 4 July 2023. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Elmar Schnee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 56,860 shares@ SEK 208.0084.8% of flowAktieISIN SE0010441584FI:csv-6646e0cfdee8e3893347
- 10,624 shares0AktieISIN SE0010441584FI:csv-9eb11d3872bfe83bf13b
- 13,000 shares@ SEK 84.06347.5% of flowAktieISIN SE0010441584FI:csv-2b57074107faaae27670Canonical exit: 1 Oct 2023 (T+90)
- 23,236 shares0AktieISIN SE0010441584FI:csv-649077f5983222dd9160
- 10,000 shares@ SEK 96.34037.7% of flowBTA (betald tecknad aktie)ISIN SE0010441584FI:csv-bcc4ee57a775a04b5621Canonical exit: 23 Nov 2021 (T+90)
5 of 5 declarations